Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463404) titled 'Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement' on March 5.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Suez Canal University
Condition:
Temporomandibular Joint Internal Derangement
Intervention:
Combination Product: Inject Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor after arthrocentesis
Recruitment Status: Not recru...